| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Mar 1, 2025 | Mar 4, 2025 | Evolent Health, Inc. | General Counsel | Sell | 95.0 | +63,758 | 38.17% | ✗ | $110.3K |
| Aug 22, 2024 | Aug 26, 2024 | Evolent Health, Inc. | General Counsel | Sell | 20.0 | -42,140 | -11.20% | ✓ | $1.3M |
| Mar 1, 2024 | Mar 5, 2024 | Evolent Health, Inc. | General Counsel | Sell | 92.5 | +9,532 | 6.05% | ✗ | $422.9K |
| Feb 22, 2024 | Feb 26, 2024 | Evolent Health, Inc. | General Counsel | Sell | 90.0 | +7,526 | 5.02% | ✗ | $132.9K |
| Mar 1, 2023 | Mar 3, 2023 | Evolent Health, Inc. | General Counsel | Sell | 90.0 | +7,163 | 5.02% | ✗ | $196.9K |
| Feb 21, 2023 | Feb 23, 2023 | Evolent Health, Inc. | General Counsel | Sell | 90.0 | +7,703 | 5.70% | ✗ | $108K |
| Aug 12, 2022 | Aug 16, 2022 | Evolent Health, Inc. | General Counsel | Sell | 20.0 | -14,335 | -9.59% | ✗ | $501.2K |
| Mar 2, 2022 | Mar 4, 2022 | Evolent Health, Inc. | General Counsel | Sell | 40.0 | -28,379 | -17.36% | ✗ | $781.6K |
| Mar 1, 2022 | Mar 3, 2022 | Evolent Health, Inc. | General Counsel | Sell | 95.0 | +17,918 | 19.52% | ✗ | $57K |
| Sep 29, 2021 | Oct 1, 2021 | Evolent Health, Inc. | General Counsel | Sell | 12.5 | -28,000 | -23.38% | ✓ | $790.2K |
| Aug 10, 2021 | Aug 11, 2021 | Evolent Health, Inc. | General Counsel | Sell | 28.8 | -8,254 | -8.25% | ✓ | $198.2K |
| Aug 6, 2021 | Aug 10, 2021 | Evolent Health, Inc. | General Counsel | Sell | 26.3 | -17,177 | -8.56% | ✓ | $413.2K |
| May 4, 2021 | May 6, 2021 | Evolent Health, Inc. | General Counsel | Sell | 17.5 | -20,000 | -17.89% | ✓ | $427.4K |
| Aug 5, 2020 | Aug 7, 2020 | Evolent Health, Inc. | General Counsel | Sell | 25.0 | -10,000 | -13.03% | ✓ | $130.1K |
| Sep 13, 2018 | Sep 14, 2018 | Evolent Health, Inc. | General Counsel | Sell | 7.5 | -15,000 | -35.91% | ✓ | $406.8K |
| May 22, 2018 | May 24, 2018 | Evolent Health, Inc. | General Counsel | Sell | 7.5 | -15,000 | -35.91% | ✓ | $300.3K |
| May 19, 2017 | May 23, 2017 | Evolent Health, Inc. | General Counsel | Sell | 20.0 | -17,230 | -51.82% | ✗ | $418.7K |
| May 3, 2017 | May 5, 2017 | Evolent Health, Inc. | General Counsel | Sell | 17.5 | -15,000 | -17.36% | ✓ | $357.8K |
| Sep 14, 2016 | Sep 15, 2016 | Evolent Health, Inc. | General Counsel | Sell | 22.5 | -10,339 | -13.56% | ✗ | $222.7K |